Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052).
Saved in:
| Title: | Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052). |
|---|---|
| Authors: | Hiroshi Asano1, Katsutoshi Oda2, Kosuke Yoshihara3, Yoichi M. Ito4, Noriomi Matsumura5, Muneaki Shimada6, Hidemichi Watari1 watarih@med.hokudai.ac.jp, Takayuki Enomoto3 |
| Source: | Journal of Gynecologic Oncology. Jul2022, Vol. 33 Issue 4, p1-12. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 20050380 |
|---|---|
| DOI: | 10.3802/jgo.2022.33.e55 |
